Clinically stable human renal allografts contain histological and RNA-based findings that correlate with deteriorating graft function.
BACKGROUND
Chronic rejection (CR) remains idiopathic, difficult to prospectively identify, and once detected, unresponsive to increased immunosuppression. We hypothesized that clinically stable human renal allografts have ongoing evidence of injury and immune activity, and that this correlates with the worsening of allograft function characteristic of CR.


METHODS
The allografts of 40 stable renal allograft recipients were biopsied 2-3 years after transplantation. Biopsies were processed for histology and RNA extraction. RNA was evaluated by semi-quantitative RT-polymerase chain reaction for CD3y mRNA (a marker of T cell receptor turnover), and mRNA from cytokine genes previously shown to be transcribed during acute rejection: tumor necrosis factor-alpha, interferon-gamma, interleukin- (IL) 1beta, IL-2, IL-4, IL-6, and IL-8. Clinical parameters including urine protein and glomerular filtration rate were measured the day of biopsy. Findings were then compared with clinical outcome to establish associations between subclinical inflammation and graft dysfunction. Allograft function was measured again 2 years after biopsy and correlated with findings at the time of biopsy.


RESULTS
Cytokine transcripts and histological evidence of injury were detected in more than two-thirds of stable grafts. The degree of the lymphocytic infiltrate correlated with the degree of proteinuria (P=0.034) and histological fibrosis (P=0.005). Similarly, the degree of intragraft CD3y transcription correlated with increasing proteinuria (P=0.043). IL-6 and IL-8 transcripts were also correlated with evidence of graft injury. After 2 years, those biopsies originally found to have evidence of fibrosis, tubular atrophy, or CD3gamma transcription had worsening graft function as determined by creatinine and glomerular filtration rate.


CONCLUSIONS
These data demonstrate that significant injury and immune activity can be detected in patients who are stable on clinical grounds. Undetected subclinical graft injury may be a cause of chronic allograft rejection.
Kirk
A D
AD
The Naval Medical Research Center, Immune Cell Biology Program, Bethesda, Maryland 20889, USA.
Jacobson
L M
LM
Heisey
D M
DM
Radke
N F
NF
Pirsch
J D
JD
Sollinger
H W
HW
D015415:Biomarkers; D001707:Biopsy, Needle; D016207:Cytokines / Q000235:genetics; D004359:Drug Therapy, Combination; D005919:Glomerular Filtration Rate; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology* / Q000502:physiology*; D012333:RNA, Messenger / Q000032:analysis* / Q000235:genetics; D017260:Receptor-CD3 Complex, Antigen, T-Cell / Q000235:genetics; D015203:Reproducibility of Results; D014184:Transplantation, Homologous
D015415:Biomarkers; D016207:Cytokines; D007166:Immunosuppressive Agents; D012333:RNA, Messenger; D017260:Receptor-CD3 Complex, Antigen, T-Cell